Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 270

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 270
---
 on February 24, 2025, the board of directors confirmed that the performance criteria has been met with regards              
 to the other installment, resulting in the vesting of the remaining 64 shares under (ii). Mr. Patel received $75,000 in consulting           
 fees pursuant to the agreement between Mr. Patel and the Company.                                                                            |

| (3) | This includes the option to purchase                                                                                               
 56 shares of Common Stock granted to the non-employee director on March 25, 2024 at an exercise price of $3,540.00 per share; such 
 award was forfeited following the director’s resignation from the board of directors.                                              |

| (4) | This includes the non-employee                                                                                                    
 director compensation for the director for the period of service prior to the director’s resignation from the board of directors. |

On March 4, 2025, granted to each non-executive director options to purchase up to 1,792 shares of Common Stock, with 50% subject to vesting on the twelve-month anniversary of the date of grant and the remaining 50% subject to performance-based vesting conditions. 160 PRINCIPAL STOCKHOLDERS The following table sets forth information regarding the beneficial ownership of our common stock as of November 24, 2025, by:

| ● | each person known by us to                                                         
 be the beneficial owner of more than 5% of our outstanding shares of Common Stock; |

| ● | each of our named executive                                                   
 officers and directors that beneficially owns shares of our Common Stock; and |

| ● | all our executive officers 
 and directors as a group.  |

Beneficial ownership is determined in accordance with the rules and regulations of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security. Shares of our Common Stock subject to options, warrants or shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock or Series E Preferred Stock that are currently exercisable or convertible or exercisable or convertible within 60 days or shares of Common Stock underlying time-based restricted stock units that vest within 60 days are considered outstanding and beneficially owned by the person holding the options, warrants, shares of preferred stock or restricted stock units, as applicable, for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person.